SUMMARY: Levels of hepatitis B "e" antigen (HBeAg) during treatment may be a more accurate predictor than hepatitis B surface antigen (HBsAg) or HBV viral load for determining which patients will respond to pegylated interferon for chronic hepatitis B, according to a study from Thailand published in the March 2010 issue of Hepatology Research.
欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) | Powered by Discuz! X1.5 |